New dissolving stent could spare kidney stone patients a second surgery

NCT ID NCT06719089

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new biodegradable stent (Hydrustent) that dissolves on its own after being placed in the ureter following kidney stone removal. The goal is to see if it keeps urine flowing safely and reduces the need for a second procedure to remove the stent. About 134 adults will be randomly assigned to get either the new stent or a standard one, and they will be followed for 3 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEPHROLITHIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Hospital CUF Tejo

    NOT_YET_RECRUITING

    Lisbon, 1350-352, Portugal

  • Unidade Local de Saúde da Região de Aveiro (ULSRA), E.P.E.

    RECRUITING

    Aveiro, Aveiro District, 3814-501, Portugal

  • Unidade Local de Saúde do Alto Minho (ULSAM)

    NOT_YET_RECRUITING

    Viana do Castelo, 4904-858, Portugal

  • Unidade Local de Unidade Local de Saúde do Alto Ave (ULSAAVE), E.P.E

    RECRUITING

    Guimarães, Braga District, 4835-044, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.